- How the different functions within Pharma/Medtech companies need to collaborate for successful HTA submissions.
- How to prepare for HTA submissions in a step by step manner, at both global and local level.
- The critical success factors when preparing HTA.
- Lessons from real-world cases.
- How the HTA process and considerations differ for orphan drugs and biosimilars.
- What the impact of the move towards EU harmonisation is on the HTA landscape.
- This is a great opportunity to review real world examples of HTA submissions and outcomes, and explore how they have impacted market access.